Ventracor Media Releases

News items from Ventracor

Click on the links below to view Australian Stock Exchange (ASX) announcements and media releases:

2008
12 August	ASX - FDA Approves Enhancements to EVERLAST™ Trial
10 July	ASX - Shareholder Update - July 2008
16 June	ASX - 50% Recruitment Achieved in US BTT Trial
19 May	ASX - Continuation of CEO Employment Contract
6 May	ASX - 250th Implant of VentrAssist® LVAD
14 April	VCR - VentrAssist LVAD US Feasibility Trial Results - ...
14 April	ASX - Results of US Feasibility Trial of the ...
4 April	ASX - Investor Update - April 2008
3 April	ASX - Change in Board Composition
17 March	ASX - Unconditional Approval of Destination Therapy ...
13 March	ASX - Destination Therapy Trial Principal Investigator
29 February	VCR - Investor Briefing - The CEO Transcript
22 February	ASX - Half Year Report and Half Year Accounts
22 February	ASX - Half Year Results Presentation
22 February	ASX - Ventracor Half Year Results - Good News Continues
11 February	ASX - Ventracor Reports 200th Implant

2007
19 December	ASX -- European Approval for New Version VentrAssist
18 December	ASX -- Approval to Use New Version VentrAssist in US ...
3 December	ASX - Major Industry Milestone - 03 Dec 2007
22 November	ASX - Shareholder update -- 20 Nov 07
20 November	ASX -- 10 active US centres -- 20 Nov 07
25 October	ASX -- Results of 2007 AGM -- 24 October 2007
24 October	ASX -- 2007 AGM Chairman's Address -- 24 October 2007
24 October	ASX - Annual General Meeting Presentation -- 24 ...
5 October	ASX -- 150 VentrAssist Implants Worldwide -- 05 Oct 07
20 September	ASX -- 2007 Notice of meeting -- 20 Spet 07
20 September	ASX -- 2007 Explanatory Memo -- 20 Sept 07
20 September	ASX -- 2007 Financial Review -- 20 Sept 07
20 September	ASX -- 2007 Annual Review -- 20 Sept 07
20 September	ASX -- 2007 Proxy form -- 20 Sept 07
5 September	ASX -- First Patient in US Destination Therapy Trial ...
16 August	ASX -- Significant Year for Ventracor -- 16 August 2007
16 August	ASX -- FY 2007 Annual Review and Results
16 August	ASX -- Appendix 4E
2 August	ASX -- TGA approval -- 1 August 2007
23 July	ASX -- Ventracor Appoints New Non-Executive Director ...
26 June	ASX -- Successful Completion of Capital Raising -- 26 ...
6 June	ASX -- Launch of US Pivotal Trial - 6 June 2007
4 June	ASX -- Growing Global Momentum Results in Strong ...
16 May	ASX -- Ventracor announces successful placement of ...
2 May	ASX -- New Directors Strengthen Board - 2 May 2007
1 May	ASX -- Principal Investigators for US Trials named - 1 ...
27 April	ASX -- First 100 Patients Clinical Data Presented - 26 ...
17 April	ASX -- Changes to Board -- 17 April 2007
11 April	VCR -- Audio Webcast CEO Peter Crosby on approval to ...
5 April	ASX -- Approval to start US BTT trial -- 05 April 2007
2 April	ASX -- 100th VentrAssist implant -- 02 April 07
28 March	VCR -- Investor Update - 28 March 2007
15 March	VCR – Audio Webcast Ventracor at Cowen and Company Annual Health Care Conference (11 mins)
7 March	VCR -- CEO to present at Cowen and Company - 07 March ...
16 February	VCR -- Audio Webcast - Half Year Results -- 14 Feb 07
14 February	VCR - Audio Webcast Half Year Results to 31 December 2006
13 February	ASX -- Innovative Trial Design Could Reduce Time to ...
13 February	ASX -- December 2006 Half Year Results - Appendix 4D
13 February	ASX -- December 2006 Half Year Results -- 13 Feb 07
13 February	ASX -- December 2006 Half Year Results Achieving ...
23 January	ASX -- Wins $2.8 million Govt Grant - 23 Jan 07
22 January	ASX -- Ventracor Continues to Build Momentum - 22 Jan ...
10 January	ASX -- Appendix 3Y - 10 Jan 07
5 January	ASX -- US BTT trial update -- 05 Jan 07
5 January	ASX -- Appendix 3B

2006
22 December	ASX - US Destination Therapy Trial Protocol Approved ...
18 December	ASX - CE Mark approval - 18 Dec 06
1 December	ASX - Appendix 3Y - 1 Dec 06
28 November	ASX - Directors and Executives will not exercise ...
17 November	ASX - FDA Approves Home Discharge for US Patients - ...
6 November	ASX - Appendix 3Y
25 October	ASX - Results of 2006 AGM
24 October	ASX - AGM address by Chairman - 24 Oct 06
24 October	ASX - AGM presentation by CEO - 24 Oct 06
23 October	ASX - Appendix 3B - 23 Oct 06
19 October	ASX - First VentrAssist Heart Recovery Featured on ...
13 October	ASX - First Case of Heart Recovery with VentrAssist™ ...
4 October	ASX - Appointment of Joint Company Secretary -- 04 Oct ...
25 September	VCR - Investor Update -- 25 Sept 2006
24 September	ASX – Explanatory Memorandum
24 September	ASX - Notice of Annual General Meeting
24 September	ASX - 2006 Annual Report -- 25 Sept 2006
11 September	ASX - CE Mark Clinical Trial Results -- 11 Sept 06
24 August	ASX - Federal Health Minister Commissions Facility -- ...
22 August	ASX - Appoints CFO -- 22 August 06
17 August	ASX - 2006 Results -- 17 August 2006
17 August	ASX - Final Results for the year ended 30 June 2006
1 August	ASX - CEO Peter Crosby Appointed Executive Director -- ...
31 July	ASX - QA system recommended for certification - 31 ...
24 July	ASX - CE submission at final stage -- Data 'very ...
3 July	ASX - FDA Changes to Accelerate US Recruitment -- 3 ...
28 June	ASX - Peter Crosby appointed CEO - 28 June 06
19 June	ASX - Preparing for EU Market Launch -- 19 June 06
16 June	ASX - Senior Govt Advisory Role for CEO - 16 June 06
15 May	VCR - Investor Update First Quarter 2006
10 May	ASX - Change of Director's Interest Notice - 10 May ...
5 May	ASX - Notice to ASX pursuant to Listing Rule 3.11.2 - ...
28 April	VCR - Artificial heart gives former diplomat new life ...
18 April	ASX - Rights Issue Closes Over Subscribed - 18 April 06
6 April	VCR - National TV coverage - 06 April 06
3 April	ASX - Expands Global Reach - 03 April 06
30 March	ASX - Directors take up rights - 30 March 06
13 March	ASX - Placement of A$22.6 million successfully ...
13 March	ASX - Appendix 3B - 13 March 06
9 March	ASX - Trading Halt - 09 March 06
21 February	ASX - Market Update - 21 February 2006
14 February	ASX - First Revenues - 14 February 2006
14 February	ASX - Half year report - Appendix 4D - 14 February 2006
8 February	ASX - Enrolment for CE Mark Trial complete - 8 ...
30 January	ASX - Fifth VentrAssist implant in US Feasibility ...
11 January	ASX - Expands US Clinical Trial Support Team - 11 ...
6 January	Transcript - Implantable Cardiac Circulatory Assist ...

Disclaimer	\|	Privacy Policy

Ventracor | Ventrassist | Investor Centre | Clinical Trials | News Room

home | contact us | glossary | faqs | sitemap